Evidence map›Paper›PMID 29508125›Full record

ArticleClinical oral investigations2018

Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts.

Tomasz Kaczmarzyk, Konrad Kisielowski, Rafał Koszowski, Magdalena Rynkiewicz, Ewa Gawełek, Karolina Babiuch, Anna Bednarczyk, Bogna Drozdzowska

Open access · hybridAbstract read
In one paragraph

Article in Clinical oral investigations, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Discovery of metabolite biomarkers for odontogenic keratocysts.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  4. Article
  5. Appearance and recurrence of odontogenic keratocysts.Clinical and experimental dental research · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tomasz KaczmarzykDepartment of Oral Surgery, Institute of Dentistry, Medical College, Jagiellonian University, ul. Montelupich 4, 31-155, Kraków, Poland. tomasz.kaczmarzyk@uj.edu.pl.
Konrad KisielowskiDepartment of Oral Surgery, Institute of Dentistry, Medical College, Jagiellonian University, ul. Montelupich 4, 31-155, Kraków, Poland.
Rafał KoszowskiAcademic Center of Dentistry and Specialized Medicine, Plac Akademicki 17, 41-902, Bytom, Poland.
Magdalena RynkiewiczDepartment of Pathomorphology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, ul. 3 Maja 13/15, 41-800, Zabrze, Poland.
Ewa GawełekDepartment of Pathomorphology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, ul. 3 Maja 13/15, 41-800, Zabrze, Poland.
Karolina BabiuchChair of Periodontology and Clinical Pathology of the Oral Cavity, Institute of Dentistry, Medical College, Jagiellonian University, ul. Montelupich 4, 31-155, Kraków, Poland.
Anna BednarczykDepartment of Oral Surgery, Institute of Dentistry, Medical College, Jagiellonian University, ul. Montelupich 4, 31-155, Kraków, Poland.
Bogna DrozdzowskaDepartment of Pathomorphology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, ul. 3 Maja 13/15, 41-800, Zabrze, Poland.
Jagiellonian University · PLMedical University of Silesia · PL

Funding

Śląski Uniwersytet Medyczny (PL) KNW-1-142/N/5/0
6 · The paper itself

Abstract

objectivesOdontogenic keratocyst (OKC) presents considerable variation in aggressiveness and propensity for recurrence, yet hitherto, no explicit clinicopathological features have been determined to clearly demonstrate the potential for relapse. This retrospective study aims to investigate the prognostic relevance of various clinicopathological features as well as immunoexpression of COX-2, bcl-2, PCNA, and p53 in sporadic OKC. MATERIALS AND

methodsAmong 41 patients with OKC treated by enucleation, the frequency of recurrence for various clinicopathological features as well as immunoexpression for COX-2, bcl-2, PCNA, and p53 was evaluated.

resultsThe mean follow-up was 8.49 years, and recurrences were ascertained in 29.27% of cases. We found significant differences between recurrent and non-recurrent cysts in terms of multilocularity (P = 0.029), cortical perforation (P = 0.001), and lesion size (P < 0.001). Hazard risk for the recurrence was 3.362 (95% CI 1.066-10.598) for multilocular cysts, 7.801 (95% CI 2.1-28.985) for evidence of cortical perforation, and 1.004 (1.002-1.006) for 1 mm

conclusionsLarger size, multilocularity, and cortical perforation in sporadic OKC may be correlated with the relapse. CLINICAL RELEVANCE: Immunohistochemical analyses of COX-2, bcl-2, PCNA, and p53 lack prognostic utility in sporadic OKC.

Indexed as

AdultBiomarkersCyclooxygenase 2FemaleHumansImmunohistochemistryMaleOdontogenic CystsPrognosisProliferating Cell Nuclear AntigenRecurrenceRetrospective StudiesTumor Suppressor Protein p53BiomarkersCyclooxygenase 2Proliferating Cell Nuclear AntigenTumor Suppressor Protein p53bcl-2COX-2Keratocystic odontogenic tumorOdontogenic keratocystp53PCNA

Identifiers

PMID29508125
PMCPMC6224022
OpenAlexW2789846832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.